FDA Approves Once-Daily Cipro XR for the Treatment of Complicated Urinary Tract Infections (cUTIs)
WEST HAVEN, Conn., Aug. 28, 2003 /PRNewswire/ -- Bayer Pharmaceuticals Corporation announced today that the U.S. Food and Drug Administration (FDA) has approved a once-daily formulation of Cipro(R) XR (ciprofloxacin* extended-release tablets) for the treatment of complicated urinary tract infections (cUTIs) and acute uncomplicated pyelonephritis (AUP), or kidney infection. The new formulation can be taken once a day for 7-14 days at a dose of 1000mg.
Content on UroToday and UroToday International Journal is copyrighted and can be used for personal, noncommercial use only. You can order presentation-ready copies for distribution to your colleagues, clients or customers by emailing UroToday at commercialreprints@urotoday.com. Request a reprint quote of this article now, please include the title of the article and number or copies requested.
|
UroToday, 1802 Fifth Street, Berkeley CA 94710 510.540.0930 (fax), info@urotoday.com ISSN 1939-4810 UroToday International Journal Correspondence
Privacy Policy | © 2010 Digital Science Press, Inc ® All Rights Reserved |
